Literature DB >> 17392476

Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls.

Masayuki Hashimoto1, Dongming Sun, Susan R Rittling, David T Denhardt, Wise Young.   

Abstract

Osteopontin (OPN) is expressed in many tissues during inflammatory responses. After spinal cord injury, microglia expresses OPN at the site of injury during the early to subacute stages. However, the function of OPN in spinal cord injury is not well understood. This study examines the responses of OPN knock-out (KO) and wild-type (WT) mice to spinal cord contusion injury. KO and WT mice were injured with a modified New York University impactor. Weights of 10 or 5.6 g were dropped 6.25 mm onto the T13 spinal cord under isoflurane anesthesia. At 24 h, homogenized spinal cords were analyzed for total potassium concentration to estimate lesion volumes. Expression of apoptotic genes, proinflammatory cytokines, and nerve growth factors was measured by reverse transcription (RT)-PCR and Western blot. In a series of animals, locomotor recovery was assessed with the Basso mouse scale (BMS) for 6 weeks, and histological analyses was performed to determine tissue preservation. Lesion volume showed no significant differences between KO and WT mice at 24 h. RT-PCR indicated that KO mice had significantly less Bcl-2, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 mRNA compared with WT controls. Western blot also showed that KO had significantly less Bcl-2 7 d after spinal cord injury. KO mice had significantly worse BMS locomotor scores than WT at 6 weeks. KO mice also had a significantly reduced area of spared white matter and fewer neuronal-specific nuclear protein-positive neurons in the spinal cord surrounding the impact site. This result supports a potential neuroprotective role for OPN in the inflammatory response to spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392476      PMCID: PMC6672107          DOI: 10.1523/JNEUROSCI.4805-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Authors:  Julie L Chan; Thomas M Reeves; Linda L Phillips
Journal:  Exp Neurol       Date:  2014-08-21       Impact factor: 5.330

2.  Identification of Regeneration and Hub Genes and Pathways at Different Time Points after Spinal Cord Injury.

Authors:  Sheng Fang; An-Quan Wang; Lin Zhong; Hui Zhang; Zong-Sheng Yin
Journal:  Mol Neurobiol       Date:  2021-01-23       Impact factor: 5.590

3.  Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice.

Authors:  Walter Maetzler; Daniela Berg; Claudia Funke; Freya Sandmann; Holger Stünitz; Corina Maetzler; Cordula Nitsch
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

4.  Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation.

Authors:  Elena Boggio; Manuela Indelicato; Elisabetta Orilieri; Riccardo Mesturini; Maria Clorinda Mazzarino; Maria Francesca Campagnoli; Ugo Ramenghi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

5.  Osteopontin Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection Against Ischemic Stroke.

Authors:  Sheng-Li Hu; Yu-Xing Huang; Rong Hu; Fei Li; Hua Feng
Journal:  Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.590

6.  Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling.

Authors:  Xin Duan; Mu Qiao; Fengfeng Bei; In-Jung Kim; Zhigang He; Joshua R Sanes
Journal:  Neuron       Date:  2015-03-05       Impact factor: 17.173

7.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

8.  Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Leila Aminova; Brett Langley; Stephen McConoughey; Ksenia Karpisheva; Hsin-Hwa Lee; Thomas Carmichael; Harley Kornblum; Giovanni Coppola; Daniel H Geschwind; Ahmet Hoke; Natalya Smirnova; Cameron Rink; Sashwati Roy; Chandan Sen; Michael S Beattie; Ron P Hart; Martin Grumet; Dongming Sun; Robert S Freeman; Gregg L Semenza; Irina Gazaryan
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Diffusion tensor imaging at 3 hours after traumatic spinal cord injury predicts long-term locomotor recovery.

Authors:  Joong H Kim; David N Loy; Qing Wang; Matthew D Budde; Robert E Schmidt; Kathryn Trinkaus; Sheng-Kwei Song
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

10.  T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

Authors:  Isaac M Chiu; Adam Chen; Yi Zheng; Bela Kosaras; Stefanos A Tsiftsoglou; Timothy K Vartanian; Robert H Brown; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.